Boxitrol Ophthalmic Ointment (400 IU+3.5 mg+5000 IU)/gm is a combination of three antibiotics used topically to treat or prevent bacterial infections in the skin. Each component has a specific spectrum of activity, providing broad coverage against a range of Gram-positive and Gram-negative bacteria. This combination is commonly found in topical ointments and creams used for wound care and minor skin infections.
This combination is used for:
| Brand Name | Boxitrol |
|---|---|
| Type | Ophthalmic Ointment |
| Weight | (400 IU+3.5 mg+5000 IU)/gm |
| Generic | Neomycin Sulfate + Bacitracin Zinc + Polymyxin B Sulfate |
| Manufacturer | Gaco Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Each component works through a different mechanism:
The effects of this topical combination can be observed within a few hours to days, depending on the severity of the infection. Initial relief from symptoms like redness, swelling, and discomfort is often noted shortly after application. Full resolution of the infection may take several days to a week, depending on the type and extent of the infection.
When applied topically, the absorption of Neomycin Sulfate, Bacitracin Zinc, and Polymyxin B Sulfate into systemic circulation is minimal. These antibiotics primarily act locally at the site of application and are not significantly absorbed through the skin.
Since these antibiotics are used topically, systemic absorption and elimination are minimal. For those few cases where systemic absorption occurs, Neomycin is primarily excreted via the kidneys, Bacitracin is mostly metabolized locally, and Polymyxin B is also primarily cleared by the kidneys.
The dosage of this combination depends on the specific formulation and the condition being treated. Typical recommendations include:
This combination is applied topically. Clean and dry the affected area before application. Use a clean applicator or your fingers to apply a thin layer of the ointment or cream. Avoid applying on large areas or open wounds without medical advice.
Possible side effects include:
Topical application minimizes the risk of systemic toxicity. However, excessive use or application to large areas of broken skin can potentially lead to systemic absorption of Neomycin, which may cause nephrotoxicity or ototoxicity. Bacitracin and Polymyxin B generally do not cause systemic toxicity but may cause local irritation or allergic reactions.
Precautions include:
Drug interactions are minimal with topical use, but caution should be observed when used in conjunction with other topical products that may cause additional irritation or allergic reactions.
Special consideration is needed for individuals with:
Topical antibiotics generally have minimal drug interactions. However, concurrent use with other topical products or medications that can cause skin irritation should be monitored.
Food interactions are not applicable as the combination is used topically. No known food interactions affect the efficacy of Boxitrol Ophthalmic Ointment (400 IU+3.5 mg+5000 IU)/gm.
During pregnancy, this topical combination should be used only if clearly needed. While systemic absorption is minimal, caution is advised, and it should be used under medical supervision. Consult a healthcare provider for appropriate use during pregnancy.
Topical use of this combination is generally considered safe during lactation due to minimal systemic absorption. However, avoid application to the breast area to prevent ingestion by the infant. Consult a healthcare provider for specific recommendations.
Acute overdose is unlikely with topical application. However, in the case of excessive application or ingestion, seek medical attention. Symptoms of overdose could include skin irritation and potential systemic effects from Neomycin.
This combination is contraindicated in individuals with:
Apply a thin layer of the ointment or cream to the affected area as directed. Do not exceed the recommended dosage. Avoid using on large or deep wounds and discontinue use if irritation or allergic reaction occurs. Consult a healthcare provider for prolonged use or if symptoms persist.
Store Boxitrol Ophthalmic Ointment (400 IU+3.5 mg+5000 IU)/gm at room temperature, away from direct sunlight and moisture. Keep the product in its original container and out of reach of children. The recommended storage temperature is between 15°C and 30°C (59°F and 86°F).
The volume of distribution for the components in this topical combination is not well-documented, as they are primarily localized to the site of application with minimal systemic absorption.
The half-life of the topical components is not well-defined due to their minimal systemic absorption. However, for systemic reference:
For systemic absorption, the clearance of Neomycin is primarily through the kidneys. Bacitracin and Polymyxin B are generally cleared via renal pathways, but systemic clearance is minimal with topical use.
See in details version Boxitrol Ophthalmic Ointment (400 IU+3.5 mg+5000 IU)/gm also Boxitrol Ophthalmic Ointment (400 IU+3.5 mg+5000 IU)/gm in bangla